Comparison of administration routes for adipose-derived stem cells in the treatment of middle cerebral artery occlusion in rats

Acta Histochemica

Volumn 116, Issue 6, 2014, Pages 1075-1084

  Du, Guojia ^a,b   Liu, Yao ^c   Dang, Muren ^b   Zhu, Guohua ^b   Su, Riqing ^b   Fan, Yandong ^b   Tan, Zeming ^a   Wang, Li Xin ^d   Fang, Jiasheng ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d Department of Neurology Guang Dong Hospital of Chinese Traditional Medicine   (China)

Author keywords

Adipose derived stem cells; Delivery route; Ischemic stroke; Middle cerebral artery occlusion; Rat

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BROXURIDINE; CASPASE 3; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 10; NEUROTROPHIC FACTOR; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; BIOLOGICAL MARKER; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADIPOSE TISSUE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CELL ISOLATION; CELL LABELING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOWN REGULATION; FEASIBILITY STUDY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; INTRAARTERIAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL DIFFERENTIATION; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; RAT; RAT MODEL; SAFETY; STEM CELL TRANSPLANTATION; UPREGULATION; ADULT STEM CELL; ANIMAL; CELL CULTURE; CELL SHAPE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION; GENETICS; INFARCTION, MIDDLE CEREBRAL ARTERY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; SUBCUTANEOUS FAT; TRANSPLANTATION;

RATTUS; RODENTIA;

ADIPOGENESIS; ADMINISTRATION, INTRAVENOUS; ADULT STEM CELLS; ANIMALS; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SHAPE; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-10; MALE; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS, SPRAGUE-DAWLEY; SUBCUTANEOUS FAT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84906056329     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.05.002     Document Type: Article

References (37)

1. Brazelton T.R., Rossi F.M., Keshet G.I., Blau H.M. From marrow to brain: expression of neuronal phenotypes in adult mice. Science 2000, 290:1775-1779.
2. Cho Y.J., Song H.S., Bhang S., Lee S., Kang B.G., Lee J.C., et al. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res 2012, 90:1794-1802.
3. Chung J.Y., Kim W., Im W., Yoo D.Y., Choi J.H., Hwang I.K., et al. Neuroprotective effects of adipose-derived stem cells against ischemic neuronal damage in the rabbit spinal cord. J Neurol Sci 2012, 317:40-46.
4. Donnan G.A., Fisher M., Macleod M., Davis S.M. Stroke. Lancet 2008, 371:1612-1623.
5. Fang Z., Yang Q., Xiong W., Li G., Xiao J., Guo F., et al. Neurogenic differentiation of murine adipose derived stem cells transfected with EGFP in vitro. J Huazhong Univ Sci Technolog Med Sci 2010, 30:75-80.
6. Gutierrez-Fernandez M., Rodriguez-Frutos B., Ramos-Cejudo J., Teresa Vallejo-Cremades M., Fuentes B., Cerdan S., et al. Effects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res Ther 2013, 4:11.
7. Jeon D., Chu K., Lee S.T., Jung K.H., Ban J.J., Park D.K., et al. Neuroprotective effect of a cell-free extract derived from human adipose stem cells in experimental stroke models. Neurobiol Dis 2013, 54:414-420.
8. Jeong S.W., Chu K., Jung K.H., Kim S.U., Kim M., Roh J.K. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 2003, 34:2258-2263.
9. Kametsu Y., Osuga S., Hakim A.M. Apoptosis occurs in the penumbra zone during short-duration focal ischemia in the rat. J Cereb Blood Flow Metab 2003, 23:416-422.
10. Kang S.K., Lee D.H., Bae Y.C., Kim H.K., Baik S.Y., Jung J.S. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003, 183:355-366.
11. Kim J.M., Lee S.T., Chu K., Jung K.H., Song E.C., Kim S.J., et al. Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model. Brain Res 2007, 1183:43-50.
12. Kim S.U., de Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 2009, 87:2183-2200.
13. Kufner A., Nolte C.H., Galinovic I., Brunecker P., Kufner G.M., Endres M., et al. Smoking-thrombolysis paradox: recanalization and reperfusion rates after intravenous tissue plasminogen activator in smokers with ischemic stroke. Stroke 2013, 44:407-413.
14. Lackland D.T., Roccella E.J., Deutsch A.F., Fornage M., George M.G., Howard G., et al. Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association. Stroke 2014, 45:315-353.
15. Leu S., Lin Y.C., Yuen C.M., Yen C.H., Kao Y.H., Sun C.K., et al. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 2010, 8:63.
16. Li D., Fang Y., Wang P., Shan W., Zuo Z., Xie L. Autologous transplantation of adipose-derived mesenchymal stem cells attenuates cerebral ischemia and reperfusion injury through suppressing apoptosis and inducible nitric oxide synthase. Int J Mol Med 2012, 29:848-854.
17. Li W.L., Yu S.P., Chen D., Yu S.S., Jiang Y.J., Genetta T., et al. The regulatory role of NF-kappaB in autophagy-like cell death after focal cerebral ischemia in mice. Neuroscience 2013, 244:16-30.
18. Liu A.M., Lu G., Tsang K.S., Li G., Wu Y., Huang Z.S., et al. Umbilical cord-derived mesenchymal stem cells with forced expression of hepatocyte growth factor enhance remyelination and functional recovery in a rat intracerebral hemorrhage model. Neurosurgery 2010, 67:357-365. discussion 65-66.
19. Liu X.L., Zhang W., Tang S.J. Intracranial transplantation of human adipose-derived stem cells promotes the expression of neurotrophic factors and nerve repair in rats of cerebral ischemia-reperfusion injury. Int J Clin Exp Pathol 2014, 7:174-183.
20. Longa E.Z., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989, 20:84-91.
21. Lu G., Kwong W.H., Li Q., Wang X., Feng Z. DT Yew, bcl2, bax, and nestin in the brains of patients with neurodegeneration and those of normal aging. J Mol Neurosci 2005, 27:167-174.
22. Mahmoudifar N., Doran P.M. Extent of cell differentiation and capacity for cartilage synthesis in human adult adipose-derived stem cells: comparison with fetal chondrocytes. Biotechnol Bioeng 2010, 107:393-401.
23. Meamar R., Dehghani L., Ghasemi M., Khorvash F., Shaygannejad V. Stem cell therapy in stroke: a review literature. Int J Prev Med 2013, 4:S139-S146.
24. Mitchell J.B., McIntosh K., Zvonic S., Garrett S., Floyd Z.E., Kloster A., et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 2006, 24:376-385.
25. Moon S.M., Kim W., Chung J.Y., Im W., Yoo D.Y., Jung H.Y., et al. Neuroprotective effects of adipose-derived stem cells are maintained for 3 weeks against ischemic damage in the rabbit spinal cord. Biomed Res Int 2014, 2014:539051.
26. Pillai D.R., Shanbhag N.C., Dittmar M.S., Bogdahn U., Schlachetzki F. Neurovascular protection by targeting early blood-brain barrier disruption with neurotrophic factors after ischemia-reperfusion in rats*. J Cereb Blood Flow Metab 2013, 33:557-566.
27. Poon W.S., Lu G., Tsang K.S., Zhu X.L., Chen G.G., Ng H.K. Migration of bone marrow stem cells in ischaemic brain. Acta Neurochir Suppl 2006, 99:123-124.
28. Ramos-Cabrer P., Campos F., Sobrino T., Castillo J. Targeting the ischemic penumbra. Stroke 2011, 42:S7-S11.
29. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
30. Savitz S.I., Dinsmore J., Wu J., Henderson G.V., Stieg P., Caplan L.R. Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 2005, 20:101-107.
31. Seshadri S., Beiser A., Kelly-Hayes M., Kase C.S., Au R., Kannel W.B., et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006, 37:345-350.
32. Sun C.K., Yen C.H., Lin Y.C., Tsai T.H., Chang L.T., Kao Y.H., et al. Autologous transplantation of adipose-derived mesenchymal stem cells markedly reduced acute ischemia-reperfusion lung injury in a rodent model. J Transl Med 2011, 9:118.
33. Walczak P., Zhang J., Gilad A.A., Kedziorek D.A., Ruiz-Cabello J., Young R.G., et al. Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 2008, 39:1569-1574.
34. Wang L., Li Y., Chen X., Chen J., Gautam S.C., Xu Y., et al. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Hematology 2002, 7:113-117.
35. Yang D., Nakajo Y., Iihara K., Kataoka H., Nakagawara J., Zhao Q., et al. An integrated stroke model with a consistent penumbra for the assessment of neuroprotective interventions. Eur Neurol 2014, 71:4-18.
36. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
37. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.